McMasters KM - Search Results

1

Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma.

Telang S, Rasku MA, Clem AL, Carter K, Klarer AC, Badger WR, Milam RA, Rai SN, Pan J, Gragg H, Clem BF, McMasters KM, Miller DM, Chesney J. Telang S, et al. Among authors: mcmasters km. BMC Cancer. 2011 Dec 13;11:515. doi: 10.1186/1471-2407-11-515. BMC Cancer. 2011. PMID: 22165955 Free PMC article. Clinical Trial.

2

Adenovirus-mediated E2F-1 gene transfer efficiently induces apoptosis in melanoma cells.

Dong YB, Yang HL, Elliott MJ, Liu TJ, Stilwell A, Atienza C Jr, McMasters KM. Dong YB, et al. Among authors: mcmasters km. Cancer. 1999 Nov 15;86(10):2021-33. doi: 10.1002/(sici)1097-0142(19991115)86:10<2021::aid-cncr20>3.0.co;2-1. Cancer. 1999. PMID: 10570427

3

The Sunbelt Melanoma Trial.

McMasters KM. McMasters KM. Ann Surg Oncol. 2001 Oct;8(9 Suppl):41S-43S. Ann Surg Oncol. 2001. PMID: 11599897 Clinical Trial.

4

A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma.

Laber DA, Okeke RI, Arce-Lara C, Taft BS, Schonard CL, McMasters KM, Kloecker GH, Miller DM. Laber DA, et al. Among authors: mcmasters km. J Cancer Res Clin Oncol. 2006 Sep;132(9):611-6. doi: 10.1007/s00432-006-0114-8. Epub 2006 Jun 2. J Cancer Res Clin Oncol. 2006. PMID: 16741726 Clinical Trial.

5

E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation.

Hao H, Dong Y, Bowling MT, Gomez-Gutierrez JG, Zhou HS, McMasters KM. Hao H, et al. Among authors: mcmasters km. BMC Cancer. 2007 Jan 30;7:24. doi: 10.1186/1471-2407-7-24. BMC Cancer. 2007. PMID: 17263886 Free PMC article.

6

Transient T cell depletion causes regression of melanoma metastases.

Rasku MA, Clem AL, Telang S, Taft B, Gettings K, Gragg H, Cramer D, Lear SC, McMasters KM, Miller DM, Chesney J. Rasku MA, et al. Among authors: mcmasters km. J Transl Med. 2008 Mar 11;6:12. doi: 10.1186/1479-5876-6-12. J Transl Med. 2008. PMID: 18334033 Free PMC article. Clinical Trial.

7

Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?

Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR. Mays MP, et al. Among authors: mcmasters km. Cancer. 2010 Mar 15;116(6):1535-44. doi: 10.1002/cncr.24895. Cancer. 2010. PMID: 20108306 Free article.

8

Immunotherapy: Tumor-infiltrating T cells--ready for prime time in melanoma?

Chesney J, McMasters KM. Chesney J, et al. Among authors: mcmasters km. Nat Rev Clin Oncol. 2011 Jul 5;8(8):449-50. doi: 10.1038/nrclinonc.2011.103. Nat Rev Clin Oncol. 2011. PMID: 21727931 No abstract available.

9

Identifying mRNA, microRNA and protein profiles of melanoma exosomes.

Xiao D, Ohlendorf J, Chen Y, Taylor DD, Rai SN, Waigel S, Zacharias W, Hao H, McMasters KM. Xiao D, et al. Among authors: mcmasters km. PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9. PLoS One. 2012. PMID: 23056502 Free PMC article.

10

Diversity of stage III melanoma in the era of sentinel lymph node biopsy.

Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC 2nd, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR. Egger ME, et al. Among authors: mcmasters km. Ann Surg Oncol. 2013 Mar;20(3):956-63. doi: 10.1245/s10434-012-2701-z. Epub 2012 Oct 14. Ann Surg Oncol. 2013. PMID: 23064795 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters